HalluciGen, Inc. terminal entries are a series of entries found on seven terminals in the HalluciGen, Inc. building in Fallout 4. The research terminal and CEO's terminal are locked, the rest are not.
Reception terminal
[Procedure: Test Subject Intake]
HalluciGen Test Subject Intake Procedure
v.1.35, 8/12/77
- Request ID. Cross-check with the day's test schedule. Verbally confirm that the visitor is a test subject, not a client.
- Offer refreshments.
- Instruct subjects to fill out intake forms 12-A through 12-H. This should allow sufficient time for the sedatives in the water to take effect.
- Notify the appropriate lab personnel.
- When instructed, complete from 12-I (dismissal), 12-J (accident report), or 12-K (fatal accident report).
[Procedure: Chemical Emergencies]
HalluciGen Chemical Emergency Procedure
Version 1.00, 3/15/76
In the unlikely event of a major chemical leak:
- Executive staff should evacuate immediately.
- Science staff should terminate any ongoing experiments. If test subjects are present, the lab manager shall determine whether to lock down the test chambers or evacuate them.
- Clerical staff should escort executives to safety, then evacuate.
Due to HalluciGen's in-building air recycling system, chemical agents may take days or weeks to disperse naturally. Do not attempt to reenter the building until cleared to do so.
Research terminal
[Activate Current Prototype]
Accessing prototype device... done.
Verifying build integrity... complete.
Commencing test. Please take appropriate safety precautions.
[View Current Prototype Details]
Prototype ID: Supressor
Firmware: v0.062.101
Electrical Output: 1450V/0.6A/500J
Status: ACTIVE
Product Object: Non-lethal target suppression via electrical discharge.
[View Lab Reports]
[Lab Report: HalluciGen Gas]
Test Protocol: 59-211-01
Product: HalluciGen Gas
Goal: Riot Pacification
Delivery Vehicle: Type-II Fragmentation Grenade
Report:
- 2/5 injured by grenade explosion (1 seriously).
- 5/5 suffered traumatic adrenal gland rupture due to gas exposure, resulting in hallucinations, erratic behaviour, increased aggression (frenzy).
- 4/5 killed in ensuing melee.
- 1/5 died due to heart failure.
Similar to previous tests. At the concentrations required for wide-area dispersal, massive adrenaline surges occur. Recommend revising the chemical substrate.
[Lab Report: Irradicator]
Test Protocol: 27-391-04
Product: HalluciGen Irradicator
Goal: Field Decontamination
Delivery Vehicle: Class-IV Ventilators (x4)
Report:
- 49/50 biochemical contaminants neutralized.
- 3/3 subjects suffered lethal doses of radiation.
- Test chamber heavily irradiated. All panels and insulation replaced.
Consider reclassifying for lethal weapons research. Irradicator power supply requires further development; current 2-ton weight unsuitable for field deployment.
[Database Network: ONLINE]
Database Network
Status: ONLINE
Main Menu
- DELETED
- DELETED
- DELETED
For your safety, this database is now property of the Brotherhood of Steel.
- Ad victoriam
Accounting terminal
[Third Quarter Financials, Draft 1]
Hallucigen
, Inc. Releases Third Quarter Financials
*Draft 1 - Not for Public Release*
HalluciGen, Inc. reported a net operating loss of $1.8 billion for the third quarter.
HalluciGen, now in its third year of operation, aspires to be the world leader in cutting-edge nonlethal technology for police and military use.
HalluciGen President and CEO Eric Rice stated:
"This has been a difficult quarter, with significant delays in several major product lines. Nonetheless, we remain optimistic about the potential of our research, and hope to achieve a positive cash flow within the next two years."
[Third Quarter Financials, Draft 2]
Hallucigen, Inc. Releases Third Quarter Financials
*Draft 2 - Not for Public Release*
HalluciGen, Inc. is pleased to report third quarter revenue of $1.1 billion.
HalluciGen, now in its third year of operation, aspires to be the world leader in cutting-edge nonlethal technology for police and military use.
HalluciGen President and CEO Eric Rice stated:
"Our long-term contracts have provided us with a strong financial foundation. In the current global political climate, we expect a tremendous demand four our products in the months and years ahead."
Observation room terminal
[Procedure: Observation Lab]
HalluciGen Observation Lab Procedure
v.2.25, 6/22/77
- Greet VIPs.
- Introduce HalluciGen, relevant products.
- Activate automated demonstration system.
- Observe automated demonstration. When malfunctions occur, trigger a different demonstration to switch focus.
- In the event of catastrophic failure, or immediately following tests of the Irradicator, escort VIPs to the conference room for a marketing presentation.
- Clear labs of test subjects, blood, fluids.
- After a test of the Irradicator, notify Facilities to replace the test chamber.
CEO's terminal
[Appointment Calendar: 10/25/77]
Appointment Calendar for
Monday, October 25th, 2077
09:00 - Senior staff briefing
10:30 - Review third quarter financials w/ Paul
11:00 - Lunch w/ Damien
12:30 - Human Subjects protocol review w/ Dr. Everill, Ethics Review Board. (Offer water)
14:00 - Greet VIP: Col. Thomas Nelson, US Army (SCYTHE)
14:30 - Review slides for procurement conference
16:00 - Post-demo sales meeting w/ Col. Nelson
[ > Safe Control]
Mainframe access terminal
[Mainframe status]
1/10 Servers: Normal
4/10 Servers: No Response / Disconnected
5/10 Serrvers: Critical Failure
1 Administrator(s) and 0 User(s) are active.
WARNING: Critical system failures have been detected. Replace the affected machines as soon as possible to prevent data loss.
Development lab terminal
[10/25 - Test Results: InvisiWave]
Test Results
Product: InvisiWave
Date: 10/25
Third test a complete success. Admiral was impressed, inquired about shipboard installations.
DM: Your 'InvisiWave' is five mirrors, two hacked Stealth Boys, and a trap door. Makes for a splashy demo, but you really crossed the line this time. Sales wants two hundred units by December. Good luck with that.
[10/21 - Test Results: Irradicator]
Test Results
Product: Irradicator
Date: 10/25
All biological and chemical contaminants destroyed. Subject and test chamber received 5100 rads radiation. Observers left the viewing room before subject's skin disintegrated. Test chamber stripped and reconstructed.
DM: So you've build a two-ton machine that irradiates people? What part of a 'hand-held field decontaminator' did you not understand? Points for getting the VIPs out before things got messy, though.
[10/18 - Test Results: Dispersant]
Test Results
Product: Dispersant
Date: 10/18
Subject survived test, failed to recover from treatment. Ran screaming at sight of own child in waiting room. Police still in pursuit.
Update: 10/20: Apprehended. Subject institutionalized.
DM: Dispersant is supposed to *stop* riots, not start them. This entire line of research is a joke. I'm transferring the project to Karyn. Send her your files and destroy your samples. Then clean out your desk.
[10/18 - Test Results: HalluciGen Gas]
Test Results
Product: HalliciGen Gas
Date: 10/18
Despite new formulation, gas still caused traumatic adrenal gland rupture and frenzy in 4/5 subjects. One survived initial exposure and began to acclimate before being beaten to death by the other subjects.
DM: Adjust dosage, retest. At least this is making progress. If marketing would just position this as a military-grade chemical weapon, we'd be done here. Would make a good grenade or artillery shell.
[10/17 - Test Results: Suppressor]
Test Results
Product: Suppressor
Date: 10/17
Subjects successfully incapacitated. Paralysis appears to be permanent. Transferred to Medford Memorial for monitoring.
DM: You were the LEAD ENGINEER on the damn Mesmetron, and you can't even get crowd pacification right? With one of your own prototypes to reverse-engineer? What, did they mezz you on the way out? You're the highest-paid researcher here. I expected better.